Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui-hua Xu

Showing results (11-20 of 445) with videos related to

Pageof 45
Sort By:
Cell|March 29, 2024
Challenges and opportunities in oncology drug development and clinical research in ChinaFeng Wang, Dan-Yun Ruan, Rui-Hua Xu
Oncotargets and Therapy|April 15, 2014
Role of capecitabine in treating metastatic colorectal cancer in Chinese patientsFeng Wang, Feng-Hua Wang, Long Bai, et al.
Cancer Communications (London, England)|June 24, 2021
Advancing to the era of cancer immunotherapyYun Wang, Min Wang, Hao-Xiang Wu, et al.
Trends in Molecular Medicine|January 27, 2021
Liquid Biopsy of Methylation Biomarkers in Cell-Free DNAHuiyan Luo, Wei Wei, Ziyi Ye, et al.
Cancer Communications (London, England)|December 30, 2023
Development of antibody-drug conjugates in cancer: Overview and prospectsDan-Yun Ruan, Hao-Xiang Wu, Qi Meng, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 12, 2005
[Effect of expression of coxsackie and adenovirus receptor on antitumor activity of genetically modified adenovirus]Zhong-Yu Yuan, Zhong-Zhen Guan, Li Zhang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|August 10, 2005
[Reverse effect of genetically modified adenovirus H101 on drug-resistance of A549/DDP cells to cisplatin]Rui-Hua Xu, Zhong-Yu Yuan, Zhong-Zhen Guan, et al.
Frontiers of Medicine|December 7, 2021
Emerging immunological strategies: recent advances and future directionsHongyun Zhao, Fan Luo, Jinhui Xue, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 22, 2003
[Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma]Zhong-Yu Yuan, Rui-Hua Xu, You-Jian He, et al.
Cancer Communications (London, England)|April 30, 2019
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?Rui-Mei Feng, Yi-Nan Zong, Su-Mei Cao, et al.
Pageof 45

Showing results (11-20 of 445) with videos related to

Sort By:
Pageof 45
Cell|March 29, 2024
Challenges and opportunities in oncology drug development and clinical research in ChinaFeng Wang, Dan-Yun Ruan, Rui-Hua Xu
Oncotargets and Therapy|April 15, 2014
Role of capecitabine in treating metastatic colorectal cancer in Chinese patientsFeng Wang, Feng-Hua Wang, Long Bai, et al.
Cancer Communications (London, England)|June 24, 2021
Advancing to the era of cancer immunotherapyYun Wang, Min Wang, Hao-Xiang Wu, et al.
Trends in Molecular Medicine|January 27, 2021
Liquid Biopsy of Methylation Biomarkers in Cell-Free DNAHuiyan Luo, Wei Wei, Ziyi Ye, et al.
Cancer Communications (London, England)|December 30, 2023
Development of antibody-drug conjugates in cancer: Overview and prospectsDan-Yun Ruan, Hao-Xiang Wu, Qi Meng, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 12, 2005
[Effect of expression of coxsackie and adenovirus receptor on antitumor activity of genetically modified adenovirus]Zhong-Yu Yuan, Zhong-Zhen Guan, Li Zhang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|August 10, 2005
[Reverse effect of genetically modified adenovirus H101 on drug-resistance of A549/DDP cells to cisplatin]Rui-Hua Xu, Zhong-Yu Yuan, Zhong-Zhen Guan, et al.
Frontiers of Medicine|December 7, 2021
Emerging immunological strategies: recent advances and future directionsHongyun Zhao, Fan Luo, Jinhui Xue, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 22, 2003
[Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma]Zhong-Yu Yuan, Rui-Hua Xu, You-Jian He, et al.
Cancer Communications (London, England)|April 30, 2019
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?Rui-Mei Feng, Yi-Nan Zong, Su-Mei Cao, et al.
Pageof 45